Top Markets
Coin of the day
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Clasificación en acciones #19712
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Precio por acción
$2.51
Capitalización bursátil
$159.66M
Cambio (1 día)
4.50%
Cambio (1 año)
0.23%
País
TW
Comercio UnicoCell Biomed Co., Ltd. (6794)

Categoría

Ratio P/B de UnicoCell Biomed Co., Ltd. (6794)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de UnicoCell Biomed Co., Ltd., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de UnicoCell Biomed Co., Ltd. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH